COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 479: Articles 4781-4790  | Next

Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome
Roberts, I., Wright Muelas, M., Taylor, J. M., Davison, A. S., Winder, C. L., Goodacre, R., Kell, D. B.
10.1101/2023.03.17.23287401 — Posted: 2023-03-17
Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
Di Fusco, M., Sun, X., Moran, M. M., Coetzer, H., Zamparo, J. M., Alvarez, M. B., Puzniak, L., Tabak, Y. P., Cappelleri, J. C.
10.1101/2023.03.15.23286981 — Posted: 2023-03-17
Increased Influenza Severity in Children in the Wake of SARS-CoV-2
Hoy, G., Maier, H. E., Kuan, G., Sanchez, N., Lopez, R., Meyers, A., Plazaola, M., Ojeda, S., Balmaseda, A., Gordon, A.
10.1101/2023.03.11.23286858 — Posted: 2023-03-16
Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in Long COVID
Al-Hakeim, H., Abed, A. K., Moustafa, S. R., Almulla, A. F., Maes, M.
10.1101/2023.03.11.23287152 — Posted: 2023-03-16
Predicting COVID-19 pandemic waves with biologically and behaviorally informed universal differential equations
Kuwahara, B., Bauch, C.
10.1101/2023.03.11.23287141 — Posted: 2023-03-16
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
Lewnard, J. A., Hong, V., Kim, J. S., Shaw, S. F., Lewin, B., Takhar, H., Lipsitch, M., Tartof, S. Y.
10.1101/2023.03.11.23287148 — Posted: 2023-03-16
Comparison of Capillary Blood Self-Collection using the Tasso-SST Device with Venous Phlebotomy for anti-SARS-CoV-2 Antibody Measurement
King, E. R., Garrett, H. E., Abernathy, H., Cassidy, C. A., Cabell, C. R., Shook-Sa, B. E., Juliano, J. J., Boyce, R. M., Aiello, A. E., Ciccone, E. J.
10.1101/2023.03.13.23286935 — Posted: 2023-03-16
Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types
McCormack, C. P., Yan, A. W. C., Brown, J. C., Sukhova, K., Peacock, T. P., Barclay, W. S., Dorigatti, I.
10.1101/2023.03.15.529513 — Posted: 2023-03-16
The highly conserved stem-loop II motif is dispensable for SARS-CoV-2
Jiang, H., Joshi, A., Gan, T., Janowski, A. B., Fujii, C., Bricker, T. L., Darling, T., Harastani, H. H., Seehra, K., Chen, H., Tahan, S., Jung, A., Febles, B., Blatter, J. A., Handley, S., Parikh, B. A., Wang, D., Boon, A. C.
10.1101/2023.03.15.532878 — Posted: 2023-03-16
Human antigen R differentially modulates the translation of SARS-CoV-2 genomic and sub-genomic RNAs
Raheja, H., Sahu, R., Ghosh, T., Rani, P., George, B., Tripathi, S., Das, S.
10.1101/2023.03.15.532790 — Posted: 2023-03-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).